Trial Profile
Administration of blinatumomab to one pediatric patient
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 08 Jun 2016 New trial record